Status:

COMPLETED

An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome

Lead Sponsor:

Boston Scientific Corporation

Conditions:

Overactive Bladder

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The goal of this study is to investigate the safety and effectiveness of a new implanted device designed to treat Urinary Urgency-Frequency Syndrome.

Eligibility Criteria

Inclusion

  • Key Inclusion criteria:
  • Age 18 years and above.
  • Diagnosed with urinary urgency-frequency syndrome.
  • Have no reported history of urethral obstruction/stricture, bladder calculi or bladder tumor.
  • Have normal upper urinary tract function.
  • Be capable of giving informed consent.
  • Be capable and willing to follow all study related procedures.
  • Key Exclusion Criteria:
  • Have any active implantable device regardless of whether stimulation status is ON or OFF.
  • Are pregnant as confirmed by a urine pregnancy test or plan to become pregnant during the following 12 month period.
  • Less than one year post partum and/or are breast-feeding.
  • Have any large passive implant that contains metal located within 30 cm of the chair pad while seated (e.g., hip replacement).
  • Have conditions requiring magnetic resonance imaging (MRI) evaluation.
  • Have conditions requiring diathermy procedures.
  • Have an inability to operate the bion Remote Control and bion Recharging System either by self or caregiver.
  • Have diabetes with peripheral nerve involvement or have severe uncontrolled diabetes.
  • Have history of coagulopathy or bleeding disorder.
  • Have pelvic pain in the absence of voiding dysfunction.
  • Have anatomical restrictions such that the study device placement is not possible.
  • Are currently participating or have participated within the past 30 days in any clinical investigation involving or impacting urinary or renal function.
  • Cannot independently comprehend and complete the questionnaires.

Exclusion

    Key Trial Info

    Start Date :

    May 1 2004

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2012

    Estimated Enrollment :

    118 Patients enrolled

    Trial Details

    Trial ID

    NCT00131573

    Start Date

    May 1 2004

    End Date

    December 1 2012

    Last Update

    November 19 2013

    Active Locations (11)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 3 (11 locations)

    1

    Arizona Health Sciences Center

    Tucson, Arizona, United States, 85724-5077

    2

    The Department of Urology, Stanford University Medical Center

    Stanford, California, United States, 94305-5118

    3

    Milestone Medical Research

    Englewood, Colorado, United States, 80112

    4

    Walter Reed Army Medical Center

    Washington D.C., District of Columbia, United States, 20307-5001